期刊文献+

纳米羟基磷灰石纤维蛋白凝胶复合重组人成骨蛋白1修复骨缺损 被引量:3

Nano-hydroxyapatite/fibrin glue/recombinant human osteogenic protein-1 for repair of bone defects
暂未订购
导出
摘要 背景:纳米级的羟基磷灰石纤维蛋白凝胶材料与人体内组织成分更为相似,具有良好的生物与力学性能,但缺乏骨诱导作用。目的:观察纳米羟基磷灰石纤维蛋白凝胶/重组人成骨蛋白1复合人工骨的骨缺损修复能力。方法:制备新西兰大白兔单侧桡骨缺损模型后,以数字表法随机分为3组,分别植入不同材料行骨缺损修复:纳米羟基磷灰石纤维蛋白凝胶/重组人成骨蛋白1人工骨组、纳米羟基磷灰石/纤维蛋白凝胶组、空白对照组(未植入任何材料)。术后4,8,12周行大体标本观察、X射线、扫描电镜、放射性核素骨扫描及生物力学测试,比较各组材料修复骨缺损的能力。结果与结论:术后4,8,12周,纳米羟基磷灰石纤维蛋白凝胶/重组人成骨蛋白1人工骨组X射线评分、成骨效果、放射性核素聚集强度、生物力学强度均高于纳米羟基磷灰石/纤维蛋白凝胶组(P < 0.05)。空白对照组骨缺损区无骨性连接,骨端硬化,骨缺损未能修复。说明纳米羟基磷灰石纤维蛋白凝胶/重组人成骨蛋白1复合人工骨具有良好的骨缺损修复能力,有望成为一种理想的骨缺损修复材料。 BACKGROUND:The nano-hydroxyapatite/fibrin glue(Nano-HA/FG) is similar to the human tissues and possesses good biological and mechanical properties,but it lacks of bone induction effect.OBJECTIVE:To investigate the repair capacity of nano-hydroxyapatite/fibrin glue/recombinant human osteogenic protein-1(Nano-HA/FG/rhOP-1) on bone defects.METHODS:Animal models of bone defects were established on the bilateral radius of New Zealand white rabbits,which were randomly divided into Nano-HA/FG/rhOP-1 artificial bone group(bone defect was repaired with artificial bone),Nano-HA/FG artificial bone group(bone defect was repaired with Nano-HA/FG artificial bone) and blank control group(bone defect was left unrepaired).The ability of repairing bone defect was evaluated by gross specimen observation,X-ray radiograph,scanning electronic microscope,radionuclide bone scan,and biomechanical test at 4,8,12 weeks after operation.RESULTS AND CONCLUSION:Radiographical scores,osteogenic effect,aggregation intensity of radionuclide,and biomechanical strength in Nano-HA/FG/rhOP-1 artificial bone group were higher than that in Nano-HA/FG group(P 0.05) at 4,8,12 weeks after operation.There was no bone connection in the defect field,bone end sclerosis,and the bone defect was not repaired in the blank control group.It suggested that Nano-HA/FG/rhOP-1 artificial bone has good repair capacity of bone defects and is expected to be an ideal repairing material for bone defect.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第8期1360-1364,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 深圳市科技计划项目资助~~
  • 相关文献

参考文献4

二级参考文献34

  • 1赵明,王会信,周廷冲.重组人骨形态发生蛋白-2成熟肽在大肠杆菌中的表达及其诱导成骨活性[J].生物化学杂志,1994,10(3):319-324. 被引量:79
  • 2祝建中,赵基栋,苗宗宁,钱寒光.体外诱导骨髓间充质干细胞分化为血管内皮细胞的实验研究[J].中国微循环,2005,9(6):409-411. 被引量:10
  • 3桑士标,董慎安,江一民,黄立新,洪天禄.^(99m)Tc—DMP骨显像在监测实验性同种异体骨移植中的价值[J].核技术,1996,19(5):314-317. 被引量:4
  • 4[1]Weisel JW,Stauffacher CV,Bulliee E,et al.A mode for fibrinogen:Domains and sequence.Science,1985,230:1 388~1 391.
  • 5[2]Doolittle RF,Watt KW,Cottrell AB,et al.The amino acid sequence of the alpha-chain of human fibrinogen.Nature,1979,280:464~468.
  • 6[3]Doolittle RF.The structure and evolution of vertebrate fibrinogen.Ann NY Acad Sci,1983,408:12~27.
  • 7[4]Crabtree GR,Comeau CM,Fowlkes,et al.Evoluation and structure of fibrinogen genes.Random insertion of introns or selective loss?J Mol Biol,1985,185:1~19.
  • 8[5]Kloczewiak M,Timmons S,Hawiger J,et al.Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain.Biochem Biophys Res Commun,1982,107:181~187.
  • 9[6]Landano AP,Doolittle RF.Synthetic pepetide derivative that bind to fibrinogen and present the polymerization of fibrin monomer.Proc Natl Acad Sci USA,1978,75:3 085~3 089.
  • 10[7]Credo RB,Curtis CG,Laorand L,et al.Alpha-chain domain of fibrinogen controls generation of fibrinoligase(coagulation factor a).Calcium ion regulatory aspects.Biochemistry,1981,20:3 770~3 778.

共引文献32

同被引文献47

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部